Autopsy report · NCT03578354

4-Aminopyridine, Atenolol, or Placebo in Patients With Vestibular Migraine

“Funding not acquired”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

Massachusetts Eye and Ear Infirmary

Sponsor type

University, hospital or other

Conditions

Vestibular Migraine; Migraine Disorders; Vestibular Diseases

Interventions

4-aminopyridine; Atenolol; Placebo

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Anti-Proliferative Effects and Genomic Alterations of Abiraterone Acetate Compared to an Aromatase Inhibitor in Post-menopausal HR+ Operable Breast Cancer
  “Funding was not acquired” (96% match in meaning)
• Effects of Steroid Tapering on Functional Capacity and Neurocognition
  “Funding not obtained” (90% match in meaning)
• Brain Sleep Deprivation MRI Effects (BEDTIME)
  “Funding was not obtained” (88% match in meaning)
• Scribes in the Emergency Department
  “Funding not received” (83% match in meaning)
• Biofilm Infection in Adults and Children Burn Injury
  “did not receive funding” (82% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.